1.
ACS Pharmacol Transl Sci
; 4(3): 1075-1078, 2021 Jun 11.
Article
in English
| MEDLINE | ID: covidwho-1233688
ABSTRACT
In this study, we investigated the interactions between SARS-CoV-2 and miRNAs associated with lung cancer using bioinformatic approaches. A special focus was placed on TMPRSS2 and lung cancer progression pathways involving AKT/PI3K/PTEN genes.
2.
ACS Pharmacol Transl Sci
; 4(1): 396-399, 2021 Feb 12.
Article
in English
| MEDLINE | ID: covidwho-989686
ABSTRACT
Cancer patients contracting SARS-CoV-2 encounter additional challenges due to inflammatory bursts and lymphopenia, which may aggravate breast cancer prognosis. In this in silico analysis, we identified the potential of miRNAs as new therapeutic targets to treat breast cancer patients infected with COVID-19 via the regulation of ADAM17 and EGFR expression microRNAs.